# Nasonex

NDC: 0113-1720
Generic name: mometasone furoate
Labeler / Manufacturer: L. Perrigo Company
Product type: HUMAN OTC DRUG
Marketing category: New Drug Application (innovator)
Dosage form: SPRAY, METERED
Routes: NASAL
Marketing started: 20220629

FDA application: NDA215712

## Active ingredients

- MOMETASONE FUROATE MONOHYDRATE: 50 ug/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0113-1720"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0113-1720
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=13696a8b-366a-4a5e-adea-d5b7bff9e46f